Hailin Tang

8PUBLICATIONS
12CO-AUTHORS
Characterisation of biological macromoleculesPoverty, inclusivity and wellbeingVeterinary virologyRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 09, 2026
Repurposing tirbanibulin as an orally active E2-targeting entry inhibitor against Chikungunya virus.

|Oct 28, 2025
The Construction and Characterization of an Infectious Clone of the Asian Genotype Chikungunya Virus from Yunnan, China.

Xinhang Ning, Binghui Xia, Zimeng Cheng

|Sep 28, 2024
Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication.

Xu Zheng, Yanhua He, Binghui Xia

|Aug 29, 2024
Nifuroxazide Prevents Chikungunya Virus Infection Both In Vitro and In Vivo via Suppressing Viral Replication.

Yangang Liu, Mingxiao Xu, Binghui Xia

|May 31, 2023
Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1 correlated with COVID-19 severity and inhibited SARS-CoV-2 infection.

Xijing Qian, Bingan Wu, Xiang Chen

|Jul 27, 2022
High-Throughput Screening of FDA-Approved Drug Library Reveals Ixazomib Is a Broad-Spectrum Antiviral Agent against Arboviruses.

Cuiling Ding, Wanda Tang, Binghui Xia

Pageof 2

Frequent Collaborators

3 joint publications

Ping Zhao

2 joint publications

Cuiling Ding

2 joint publications

Xu Zheng

1 joint publications

Jing-Wen Gu